Drawing for CELLCARTA

USPTO serial 90522686

CELLCARTA

Reviewed by CopyMark Law Group

Reg. 7868259Status 700Registered
Filing date
Status date
Registration date
Jul 15, 2025
Examiner
RINKER, ANTHONY MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CELLCARTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Keith Toms, Esq.

Keith Toms, Esq. MCCARTER & ENGLISH, LLP265 FRANKLIN STREETBOSTON, MA 02110-3113United States

Goods and services

ClassDescriptionStatusFirst use
009Specimen collection kits for scientific and medical research, comprised of specimen containers, vials, and caps; Specimen collection kits for clinical trial research, comprised of specimen containers, vials, and caps; plastic and glass tubes and vials for scientific and medical research sample collection and storage; Testing sample collection equipment, namely, tubes and vials, for use in experimental testing, not for medical purposesACTIVE—
016Printed shipping labels; printed paper labels; printed paper labels for use on laboratory specimens; paper bar code labels; printed forms used in clinical trials; printed labels for use in organizing and tracking specimens for clinical trials; printed paper packaging materials for clinical trial sample collection kitsACTIVE—
039Transportation and storage of goods, namely, clinical trial materials; transportation and storage of goods; transportation and storage of laboratory and clinical trial specimen collection kits; Shipping and delivery services, namely, pickup, transportation, and delivery of laboratory and clinical trial specimen collection kits; transportation of goods in ambient or temperature controlled conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 16, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 15, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 15, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 24, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 2, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 2, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 1, 2025IUAFUSE AMENDMENT FILED—
Mar 26, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 25, 2025EX5GSOU EXTENSION 5 GRANTED—
Mar 25, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 27, 2024EXT5SOU EXTENSION 5 FILED—
Nov 27, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 31, 2024EX4GSOU EXTENSION 4 GRANTED—
May 31, 2024EXT4SOU EXTENSION 4 FILED—
May 31, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 29, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 28, 2023EX3GSOU EXTENSION 3 GRANTED—
Nov 28, 2023EXT3SOU EXTENSION 3 FILED—
Nov 28, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 28, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 26, 2023EX2GSOU EXTENSION 2 GRANTED—
Apr 26, 2023EXT2SOU EXTENSION 2 FILED—
Apr 26, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 1, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 30, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 28, 2022EX1GSOU EXTENSION 1 GRANTED—
Nov 28, 2022EXT1SOU EXTENSION 1 FILED—
Nov 28, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 31, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 5, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 5, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 16, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 28, 2022ALIEASSIGNED TO LIE—
Feb 25, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 25, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Feb 25, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 25, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 25, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 27, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2021DOCKASSIGNED TO EXAMINER—
May 14, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 15, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance